Benjamin F. Edwards & Company, Inc. Biomarin Pharmaceutical Inc Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 391 shares of BMRN stock, worth $25,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares

391

Previous 394 0.76%

Holding current value

$25,673

Previous $35,000 8.57%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$74.43 - $92.22 $223 - $276	-3 Reduced 0.76%	391 $32,000
Q1 2024 Apr 29, 2024	SELL	$83.81 - $99.0 $3,268 - $3,861	-39 Reduced 9.01%	394 $35,000
Q4 2023 Feb 06, 2024	BUY	$76.22 - $98.51 $18,978 - $24,528	249 Added 135.33%	433 $42,000
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $3,743 - $4,157	-44 Reduced 19.3%	184 $16,000
Q1 2023 Apr 27, 2023	SELL	$87.74 - $117.27 $1,579 - $2,110	-18 Reduced 7.32%	228 $22,000
Q4 2022 Feb 07, 2023	BUY	$80.93 - $108.63 $3,479 - $4,671	43 Added 21.18%	246 $25,000
Q3 2022 Oct 28, 2022	SELL	$82.16 - $96.94 $84,296 - $99,460	-1,026 Reduced 83.48%	203 $17,000
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $109,078 - $132,533	-1,526 Reduced 55.39%	1,229 $102,000
Q1 2022 May 04, 2022	SELL	$74.28 - $92.69 $56,304 - $70,259	-758 Reduced 21.58%	2,755 $212,000
Q4 2021 Feb 07, 2022	BUY	$71.72 - $91.47 $20,511 - $26,160	286 Added 8.86%	3,513 $310,000
Q3 2021 Nov 02, 2021	SELL	$74.77 - $85.47 $50,843 - $58,119	-680 Reduced 17.4%	3,227 $249,000
Q2 2021 Aug 11, 2021	SELL	$75.51 - $84.79 $12,685 - $14,244	-168 Reduced 4.12%	3,907 $326,000
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $75,626 - $91,778	1,012 Added 33.04%	4,075 $308,000
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $111,964 - $139,088	1,542 Added 101.38%	3,063 $269,000
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $22,567 - $41,143	314 Added 26.01%	1,521 $116,000
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $94,505 - $147,573	1,188 Added 6252.63%	1,207 $149,000
Q4 2019 Feb 06, 2020	SELL	$64.27 - $86.37 $59,128 - $79,460	-920 Reduced 97.98%	19 $2,000
Q3 2019 Nov 05, 2019	BUY	$67.4 - $85.11 $60,188 - $76,003	893 Added 1941.3%	939 $63,000
Q2 2019 Aug 08, 2019	BUY	$80.35 - $93.9 $1,526 - $1,784	19 Added 70.37%	46 $4,000
Q4 2017 Jan 17, 2018	SELL	$80.76 - $95.13 $1,211 - $1,426	-15 Reduced 35.71%	27 $2,000
Q3 2017 Oct 24, 2017	BUY	$80.6 - $94.95 $3,385 - $3,987	42	42 $4,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Biomarin Pharmaceutical Inc Transaction History